Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP Guideline study (OECD 471), with a deviation (2-AA was used as sole indicator of the efficiancy of the S9-mix

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1999
Report date:
1999

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
yes
Remarks:
2-AA was used as sole indicator of the efficacy of the S9-mix.
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Tripropylamine
EC Number:
203-047-7
EC Name:
Tripropylamine
Cas Number:
102-69-2
Molecular formula:
C9H21N
IUPAC Name:
tripropylamine
Test material form:
other: solution
Details on test material:
- Name of test material (as cited in study report): Tripropylamin
- Physical state: colorless liquid
- Analytical purity: 98.7 g/100 g (GC)
- Lot/batch No.: Behälter 960
- Storage condition of test material: room temperature

Method

Target gene:
his operon, trp operon
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Metabolic activation system:
The S9 fractions were prepared from the liver of Aroclor 1254-induced male Sprague-Dawley rats
Test concentrations with justification for top dose:
Standard plate test: 0, 20, 100, 500, 2500, 5000 µg/plate (S. typhimurium and E. coli)
Preincubation test: 0, 4, 20, 100, 500, 2500 µg/plate (S. typhimurium); 0, 20, 100, 500, 2500, 5000 µg/plate (E. coli).
Vehicle / solvent:
- Vehicle/solvent used: acetone
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
acetone
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: with S-9 mix: all strains 2-aminoanthracene; without S-9 mix: strains TA100, TA1535: N-methyl-N'-nitro-N-nitrosoguanidine; TA98: 4-nitro-o-phenylendiamine; TA1537: 9-aminoacridine; E.coli WP2 uvrA: N-ethyl-N'-nitro-N-nitrosoguanidine.
Details on test system and experimental conditions:
METHOD OF APPLICATION: preincubation
DURATION
- Preincubation period: 20 min
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth

METHOD OF APPLICATION: standard plate test
DURATION
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
Evaluation criteria:
The test chemical is considered positive in this assay if the following criteria are met: A dose-related and reproducible increase in the number of revertant colonies, i.e. about doubling of the spontaneous mutation rate in at least one tester strain either without S-9 mix or after adding a metabolizing system.
A test substance is generally considered non-mutagenic in this test if: The number of revertants for all tester strains are within the historical negative control range under all experimental conditions in two experiments carried out independently of each other.

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
Standard plate test: depending on the strain and test conditions from about 2,500 µg/plate onward. Preincubation assay: depending on the strain and test conditions from about 100 µg - 500 µg/plate onward.
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
In the preincubation assay bacteriotoxicity was observed depending on the strain and test conditions from about 2500 µg/plate onward.
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: No test substance precipitation was found.


Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Standart plate test:

 Dose (µg/plate)  TA1535     TA100     TA1537     TA98        E. coli WP2 uvrA
   -S9  +S9  -S9  +S9  -S9  +S9 -S9  +S9 -S9  +S9 
 0

19±1

19±1

105±4

112±3

9±1

10±1

24±2

33±3

32±4

31±4

20 

18±2

15±1

103±6

108±8

10±1

11±2

21±3

30±1

29±4

30±3

 100

14±3

16±2

98±7

108±2

9±1

11±2

18±1

34±3

27±1

32±5

 500

15±2

16±3

103±3

117±6

6±2

10±2

19±1

27±6

24±3

34±1

 2500

6±3

13±2

100±2

106±8

7±2

7±1

20±1

25±3

24±2

28±3

 5000

10±

14±4X

102±3

94±6X

7±2

4±2X

16±2

29±4

25±5

28±7

 2 -AA

-

156±1

-

1191±131

 -

187±4

1823±73

 -

199±7

 MNNG

 848±44

-

1005±8

-

-

 -

-

 -

-

-

 AAC

-

-

-

-

1204±7

-

-

-

-

-

 NOPD

 -

-

-

-

-

-

698±17

-

 ENNG

 -

-

-

-

-

-

-

-

940±50

-

Mean ± SD

Preincubation-test:

 Dose (µg/plate)

 TA1535   

 TA100   

 TA1537   

 TA98   

 E. coli

WP2 uvrA   

 

 -S9

 +S9

 -S9

 +S9  -S9  +S9 -S9  +S9  -S9 +S9 
 0

21±1

20±2

115±3

111±9

11±2

11±1

29±2

39±1

28±3

37±6

4

19±0

17±1

110±15

106±10

9±2

10±2

26±3

26±5

-

-

 20

18±3

17±3

103±8

112±9

9±2

9±1

20±2

25±6

26±4

27±5

 100

17±1

16±3

103±8

108±7

9±2

8±2

18±2

23±2

23±2

22±2

 500

15±2

11±2

113±10

105±14

10±1

6±2

17±4

21±2

21±2

19±3

 2500

X

X

X

X

X

X

X

X

18±4

16±4

 5000

-

-

-

.-

-

-

X

X

2-AA

-

140±33

-

1039±31

-

150±8

-

973±20

-

210±12

 MNNG

1166±47

-

1329±21

-

-

-

-

-

-

-

 AAC

-

-

-

-

697±27

-

-

-

-

-

NOPD

-

-

-

-

-

-

677±4

-

-

-

 ENNG   -  -  -

 - -   -  903±66  -

Mean ± SD

X: reduced background growth

2-AA: 2-aminoanthracene;

MNNG; N-methyl-N-nitro-N-nitrosoguanidine

ENNG; N-ethyl-N-nitro-N-nitrosoguanidine

NOPD: 4-nitro-o-phenylendiamine

AAC: 9-aminoacridine chloride monohydrate

Under the conditions tested Tripropylamine is non mutagenic in the bacterial AMES-test.

The positive controls gave the expected values.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

Tripropylamine was negative in the Standard Plate Test and in the Preincubation Test.
Executive summary:

Tri-n-propylamine was tested for its mutagenic activity in the Salmonella - Escherichia coli/Mammalian-Microsome Reverse Mutation Assay. The tester strains used in the mutagenicity assay were Salmonella typhimurium tester strains TA98, TA100, TA1535, TA1537, and Escherichia coli tester strain WP2uvrA. The assay was conducted with five doses of the test article in the presence and the absence of S9 mix along with concurrent vehicle and positive controls using three plates per dose. The doses tested were 0, 20, 100, 500, 2500, 5000 µg/plate in the standard plate test (Salmonella typhimurium and E. coli) and 0, 4, 20, 100, 500, 2500 µg/plate (Salmonella typhimurium) and 0, 20, 100, 500, 2500, 5000 µg/plate (E. coli) in the preincubation test. The experiments were performed in the presence and absence of S9 mix.

The results show that, under the conditions of this study, tri-n-propylamine did not cause a positive increase in the number of revertants per plate of any of the tester strains either in the presence or absence of microsomal enzymes prepared from Aroclor™-induced rat liver (S9).